Trial Profile
Rivaroxaban versus enoxaparin sodium in patients with acute decompensated heart failure
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2011
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Enoxaparin sodium
- Indications Thromboembolism
- Focus Pharmacodynamics; Pharmacokinetics
- 08 Feb 2011 New trial record